Highcape Partners Management

Venture Capital Exempt reporting adviser

Legal name: Highcape Capital, L.P.

Westport, CT Website LinkedIn

AUM

$48.0M
Private fund assets

Private funds

11
Venture Capital 11

Private fund assets

$48.0M
Gross asset value

Employees

—

Last Form D raise

Apr 2020
Most recent fund filing

From SEC Form ADV filing (filed Mar 31, 2026). View on SEC

People(1)

Owners and executive officers named on the firm's SEC Form ADV.

K
Sole Member of Highcape Capital, LLC, Highcape Capital

Funds(11)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Highcape Partners Qp II, LPVenture Capital$37.8M$55.3M46Apr 2020Cold
Highcape Partners II, LPVenture Capital$787K$1.1M9Apr 2020Cold
Highcape Special Opportunities 4-A, LLCVenture Capital$2.1M———
Highcape Special Opportunities 4-B, LLCVenture Capital$1.7M———
Highcape Special Opportunities 3-B, LLCVenture Capital$899K———
Highcape Alphina Co-Invest I, LLCVenture Capital$862K———
Highcape Special Opportunities 2-B, LLCVenture Capital$834K———
Highcape Special Opportunities 2-A, LLCVenture Capital$833K———
Highcape Special Opportunities 1-A, LLCVenture Capital$727K———
Highcape Special Opportunities 1-B, LLCVenture Capital$727K———
Highcape Special Opportunities 3-A, LLCVenture Capital$682K———

Board seats(9)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Convexity Scientific
Other Health CareNew Haven, CTDirector: Kevin Rakin
$49.9M raised
Since Oct 2019
SEC Form D
Allyx Therapeutics
BiotechnologyNew Haven, CTDirector: Kevin Rakin
$39.6M raised
Since May 2026
SEC Form D
Alphina Therapeutics
BiotechnologyNew Haven, CTDirector: Kevin Rakin
$17.0M raised
Since Sep 2021
SEC Form D
CapeHaven Holding
BiotechnologyNew Haven, CTDirector: Kevin Rakin
$1.4M raised
Since Jul 2025
SEC Form D
Modifi Biosciences
BiotechnologyNew Haven, CTDirector: Kevin Rakin
$11.5M raised
Since Apr 2022
SEC Form D
Cybrexa Holding
OtherNew Haven, CTDirector: Kevin Rakin
$42.4M raised
Since Jan 2020
SEC Form D
Aztek Bio
BiotechnologyWestport, CTDirector: Kevin Rakin
$935K raised
Since Nov 2021
SEC Form D
CyOmics
BiotechnologyNew Haven, CTDirector: Kevin Rakin
$1.9M raised
Since Jan 2017
SEC Form D
CyOmics
BiotechnologyOld Saybrook, CTDirector: Kevin Rakin
$700K raised
Since Mar 2015
SEC Form D

Regulatory identifiers

CRD number
170971
SEC file number
802-79517

Sources